Nanalysis

Nanalysis Reports Third Quarter 2022 Results

Retrieved on: 
Tuesday, November 29, 2022
Marketing, Growth, OTC, Agrochemical, AB, Food, Conference, Multimedia, HERE, TSX Venture Exchange, Security Service, Government, Security, CATSA, Q&A, Law enforcement, The Company, Canada, NMR, MRI, News, Mining, NSCI, Hertz, Research, Economic development, Depreciation, Business, Investment, FRA, Acquisition, Nuclear magnetic resonance, Canadian Air Transport Security Authority, Video game, Renewable energy, Medical device, Bank, Mobile phone, Medical imaging, Nanalysis

CALGARY, AB, Nov. 29, 2022 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, releases its second quarter results endingSeptember 30, 2022.

Key Points: 
  • CALGARY, AB, Nov. 29, 2022 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, releases its second quarter results endingSeptember 30, 2022.
  • Chief Executive Officer,Sean Krakiwskyand Interim Chief Financial Officer,Randall McRaewill host a conference call at5 P.M. Eastern Timetodayto discuss the results.
  • "I am pleased to report we have returned to our strong growth trajectory in the third quarter," saidSean Krakiwsky, Founder and CEO of Nanalysis.
  • We expect to see continued strength in our business in the fourth quarter, which has historically been a strong quarter for our business."

Nanalysis Announces Third Quarter 2022 Conference Call

Retrieved on: 
Tuesday, November 15, 2022
Conference, Technology, Nuclear magnetic resonance, Acquisition, Government, Intention, News, Daou Technology Inc., Forward-looking statement, AB, TSX Venture Exchange, Q&A, NSCI, Industry, The Company, Interim, View, Company, Ownership, Law enforcement, Mining, Multimedia, NMR, FRA, Food, Nanalysis, MRI, OTC, Agrochemical, OTCQX, Financial services, Medical imaging

Investors interested in participating on the live second quarter call can dial 1-888-664-6392 or 416-764-8659 from abroad.

Key Points: 
  • Investors interested in participating on the live second quarter call can dial 1-888-664-6392 or 416-764-8659 from abroad.
  • The webcast will be archived on the Company's investor relations webpage for at least 90 days and a telephonic playback will be available for seven days after the conference call by calling 1-888-390-0541 or 416-764-8677, conference ID #833132.
  • Nanalysis trades on the TSX Venture Exchange (TSXV) inCanadawith ticker symbol 'NSCI', OTC and theFrankfurtexchange under the ticker symbol '1N1'.
  • Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Nanalysis to Present at LD Micro Main Event XV Investor Conference Presentation is Tuesday, Oct. 25th at 2:00pm PT

Retrieved on: 
Tuesday, October 18, 2022
News, FSE, Government, Nuclear magnetic resonance, Conference, Nanalysis, MRI, Technology, Company, Acquisition, Industry, TSX Venture Exchange, Law enforcement, CEO, Intention, Agrochemical, OTC, Food, Forward-looking statement, NSCI, Ownership, NMR, Mining, Medical imaging, Fine chemical

Nanalysis CEO Sean Krakiwsky will be presenting at the LD Micro Conference in Los Angeles on Tuesday, Oct. 25th at 2:00pm PT in Track 2.

Key Points: 
  • Nanalysis CEO Sean Krakiwsky will be presenting at the LD Micro Conference in Los Angeles on Tuesday, Oct. 25th at 2:00pm PT in Track 2.
  • Mr. Krakiwsky will be available in person for 1x1 meetings on Tuesday, Oct 25th and Wednesday, Oct 26th.
  • Nanalysis trades on the TSX Venture Exchange (TSXV) in Canada with ticker symbol 'NSCI', OTC and the Frankfurt exchange under the ticker symbol '1N1'.
  • Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Nanalysis Provides Corporate Update

Retrieved on: 
Thursday, October 20, 2022
News, Government, Nuclear magnetic resonance, Growth, Conference, Multimedia, MRI, Technology, Airport, Company, FRA, Mining, CATSA, Industry, Acquisition, TSX Venture Exchange, Law enforcement, CEO, Intention, Agrochemical, OTCQX, OTC, Food, Security, Forward-looking statement, NSCI, AB, Security Service, Ownership, The Company, Party, NMR, View, Medical imaging, Pharmaceutical industry, Video game, Fine chemical, Quad, Nanalysis

Presenting at LD Micro Conference on Oct. 25th

Key Points: 
  • Presenting at LD Micro Conference on Oct. 25th
    CALGARY, AB, Oct. 20, 2022 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, provides a corporate update on operations.
  • "We have seen a strong return to our growth trajectory in our core NMR business," saidSean Krakiwsky, Founder and CEO of Nanalysis.
  • Nanalysis CEO Sean Krakiwsky will be presenting at the LD Micro Conference in Los Angeles on Tuesday, Oct. 25th at 2:00pm PT in Track 2.
  • Nanalysis trades on the TSX Venture Exchange (TSXV) inCanadawith ticker symbol 'NSCI', OTC and theFrankfurtexchange under the ticker symbol '1N1'.

Nanalysis Scientific Corp. Announces Grant of Stock Options

Retrieved on: 
Tuesday, August 30, 2022
Nanalysis, Mining, AB, Food, Agrochemical, Nuclear magnetic resonance, OTC, Government, Ownership, Board, TSX Venture Exchange, Multimedia, Intention, Board of directors, Company, News, FRA, MRI, Special-purpose acquisition company, Law enforcement, NMR, Acquisition, Industry, Forward-looking statement, NSCI, Security (finance), Medical imaging, Fine chemical

CALGARY, AB, Aug. 30, 2022 /PRNewswire/ - Nanalysis Scientific Corp. (TSXV:NSCI) (OTCQX: NSCIF) (FRA: 1N1) ("Nanalysis" or the "Company") announces that the Company's Board of Directors has granted a total of 377,500 stock options to its employees, including 175,000 to an officer, pursuant to the Company's stock option plan.

Key Points: 
  • CALGARY, AB, Aug. 30, 2022 /PRNewswire/ - Nanalysis Scientific Corp. (TSXV:NSCI) (OTCQX: NSCIF) (FRA: 1N1) ("Nanalysis" or the "Company") announces that the Company's Board of Directors has granted a total of 377,500 stock options to its employees, including 175,000 to an officer, pursuant to the Company's stock option plan.
  • The options vest as to one-third on each of the 12 month, 24 month and 36 month anniversary date of grant.
  • Nanalysis trades on the TSX Venture Exchange (TSXV) inCanadawith ticker symbol 'NSCI', OTC and theFrankfurtexchange under the ticker symbol '1N1'.
  • Nanalysis recently announced that it has begun selling a 100MHz device in 2020.

Nanalysis Announces Second Quarter 2022 Conference Call

Retrieved on: 
Wednesday, August 10, 2022
Q&A, Multimedia, Interim, AB, Industry, Forward-looking statement, NSCI, The Company, Technology, TSX Venture Exchange, Law enforcement, Government, Nuclear magnetic resonance, Daou Technology Inc., Company, Food, Acquisition, Nanalysis, View, OTC, FRA, Intention, News, Ownership, NMR, Agrochemical, Conference, MRI, Mining, Financial services, Medical imaging

Investors interested in participating on the live second quarter call can dial 1-888-664-6392 or 416-764-8659 from abroad.

Key Points: 
  • Investors interested in participating on the live second quarter call can dial 1-888-664-6392 or 416-764-8659 from abroad.
  • The webcast will be archived on the Company's investor relations webpage for at least 90 days and a telephonic playback will be available for seven days after the conference call by calling 1-888-390-0541 or 416-764-8677, conference ID #484317.
  • Nanalysis trades on the TSX Venture Exchange (TSXV) inCanadawith ticker symbol 'NSCI', OTC and theFrankfurtexchange under the ticker symbol '1N1'.
  • Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Nanalysis Scientific Corp. Announces Management Transitions

Retrieved on: 
Thursday, July 21, 2022
CA, MRI, LLP, Acquisition, Food, CFO, University, TSX Venture Exchange, Randall, Industry, Daou Technology Inc., Forward-looking statement, AB, Government, Hotel manager, Solution, Intention, Ownership, Randalls, Agrochemical, Institute, Commerce, Board, Partner, NMR, News, Mining, MNP, FRA, Director, Technology, Company, Nuclear magnetic resonance, NSCI, Law enforcement, Market for corporate control, CPA, Entrepreneurship, Growth, Automation, OTC, Audit, Nanalysis

CALGARY, AB, July 21, 2022 /PRNewswire/ - Nanalysis Scientific Corp. (TSXV:NSCI) (OTCQX: NSCIF) (FRA: 1N1) ("Nanalysis" or the "Company") announces that the current CFO, Luke Caplette, is stepping down as CFO, but will remain with the Company as a part-time consultant to assist the transition to a new CFO.

Key Points: 
  • CALGARY, AB, July 21, 2022 /PRNewswire/ - Nanalysis Scientific Corp. (TSXV:NSCI) (OTCQX: NSCIF) (FRA: 1N1) ("Nanalysis" or the "Company") announces that the current CFO, Luke Caplette, is stepping down as CFO, but will remain with the Company as a part-time consultant to assist the transition to a new CFO.
  • "We wish to thank Luke for his tremendous contribution to Nanalysis as CFO over the last three years.
  • "Randall has worked for Nanalysis for the past six months as a consultant and will provide solid continuity during this transition.
  • Nanalysis trades on the TSX Venture Exchange ("TSXV") inCanadawith ticker symbol 'NSCI', OTC and theFrankfurtexchange under the ticker symbol '1N1'.

Nanalysis Announces Results of AGM and Appointment of New Director

Retrieved on: 
Thursday, June 23, 2022
Industry, Ernst & Young, View, Government, Meeting, Company, OTC, Forward-looking statement, Ownership, Metrohm, Intention, NSCI, Acquisition, News, Mining, MRI, Food, Nanalysis, TSX Venture Exchange, Board of directors, NMR, Law enforcement, Agrochemical, Board, Agilent Technologies, Multimedia, Nuclear magnetic resonance, Medical imaging, Fine chemical, Audit, Leidos

Mr. Lin is currently a Managing Director at Nanalysis and was formerly the President and Chief Executive Officer of KPrime Technologies before the Company's acquisition by Nanalysis.

Key Points: 
  • Mr. Lin is currently a Managing Director at Nanalysis and was formerly the President and Chief Executive Officer of KPrime Technologies before the Company's acquisition by Nanalysis.
  • KPrime has a portfolio of sales and services in scientific detection and measuring equipment, financing, and asset management for chemical and security industries.
  • Mr. Lin resides and works in Calgary, Alberta, Canada but also splits time in Phoenix, Arizona at KPrime Headquarters.
  • Nanalysis trades on the TSX Venture Exchange (TSXV) inCanadawith ticker symbol 'NSCI', OTC and theFrankfurtexchange under the ticker symbol '1N1'.

Nanalysis Announces First Quarter 2022 Conference Call and Virtual Annual General Meeting

Retrieved on: 
Tuesday, May 24, 2022
Daou Technology Inc., COVID-19, Company, Public health, Food, Annual, News, Multimedia, TSX Venture Exchange, MRI, SEDAR, View, Government, OTC, AGM, Mining, Law enforcement, Ownership, AB, Nanalysis, Industry, Intention, The Company, Nuclear magnetic resonance, Forward-looking statement, Technology, Proxy, Annual general meeting, NSCI, Acquisition, FRA, NMR, Agrochemical, Video game, Medical imaging

The Company will file with SEDAR the day before and put out a release the day of the call.

Key Points: 
  • The Company will file with SEDAR the day before and put out a release the day of the call.
  • Investors interested in participating on the live first quarter call can dial 1-888-664-6392 or 416-764-8659 from abroad.
  • Nanalysis trades on the TSX Venture Exchange (TSXV) inCanadawith ticker symbol 'NSCI', OTC and theFrankfurtexchange under the ticker symbol '1N1'.
  • Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Nanalysis Announces Fourth Quarter and Full Year 2021 Conference Call

Retrieved on: 
Wednesday, April 20, 2022
News, FRA, Government, Nanalysis, AB, Nuclear magnetic resonance, Law enforcement, Intention, MRI, Agrochemical, TSX Venture Exchange, The Company, OTCQX, OTC, Food, Company, NSCI, Mining, Forward-looking statement, NMR, Daou Technology Inc., Multimedia, Industry, Acquisition, View

Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Luke Caplette will host a conference call at 5:00 P.M. Eastern Time that same day.

Key Points: 
  • Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Luke Caplette will host a conference call at 5:00 P.M. Eastern Time that same day.
  • Investors can also access the call online through a listen-only webcast here: https://app.webinar.net/YQa2M3LDolK ,or on the investor relations section of the Company's website HERE .
  • Nanalysis trades on the TSX Venture Exchange (TSXV) inCanadawith ticker symbol 'NSCI', OTC and theFrankfurtexchange under the ticker symbol '1N1'.
  • Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.